ReviewBritish journal of haematology2025
How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome.
Valeria Santini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it